We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
(-3%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Amazon
AMZN
|
+$99.5M |
| 3 |
Microsoft
MSFT
|
+$95.8M |
| 4 |
Linde
LIN
|
+$84.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$77.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$14.7M |
| 4 |
CA
CA, Inc.
CA
|
+$13.2M |
| 5 |
Clorox
CLX
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 13.08% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Consumer Staples | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRS
1476
DELISTED
Amyris Inc.
AMRS
| $97K | ﹤0.01% |
+29,172
| New | +$168K |
|
|
HMHC
1477
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $97K | ﹤0.01% |
10,904
-1,757
| -14% | -$13.9K |
|
|
ACHN
1478
DELISTED
Achillion Pharmaceuticals
ACHN
| $97K | ﹤0.01% |
61,311
-11,837
| -16% | -$33.5K |
|
|
GLUU
1479
DELISTED
Glu Mobile Inc.
GLUU
| $95K | ﹤0.01% |
11,756
-1,895
| -14% | -$13.5K |
|
|
AKS
1480
DELISTED
AK Steel Holding Corp
AKS
| $95K | ﹤0.01% |
42,316
-4,484
| -10% | -$16.2K |
|
|
CHS
1481
DELISTED
Chicos FAS, Inc.
CHS
| $94K | ﹤0.01% |
16,760
-2,191
| -12% | -$15.3K |
|
|
GOV
1482
DELISTED
Government Properties Income Trust
GOV
| $91K | ﹤0.01% |
13,188
-1,395
| -10% | -$12.4K |
|
1483
Adicet Bio
ACET
$72.8M
| $89K | ﹤0.01% |
+92
| New | +$121K |
|
|
HAPN
1484
Happen Inc
HAPN
$2.08B
| $89K | ﹤0.01% |
6,766
-970
| -13% | -$16K |
|
|
KDNY
1485
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $89K | ﹤0.01% |
6,735
-1,283
| -16% | -$25.6K |
|
|
NE
1486
DELISTED
Noble Corporation
NE
| $89K | ﹤0.01% |
33,967
-3,705
| -10% | -$17.6K |
|
1487
Coeur Mining
CDE
$15.6B
| $87K | ﹤0.01% |
19,567
-3,128
| -14% | -$14.8K |
|
|
FSP
1488
Franklin Street Properties
FSP
$44.8M
| $87K | ﹤0.01% |
13,998
-1,468
| -9% | -$10.8K |
|
1489
Arbutus Biopharma
ABUS
$865M
| $86K | ﹤0.01% |
22,521
-4,390
| -16% | -$21.6K |
|
|
TRST
1490
Trustco Bank Corp NY
TRST
$1B
| $86K | ﹤0.01% |
2,519
-260
| -9% | -$9.84K |
|
|
RCM
1491
DELISTED
R1 RCM Inc. Common Stock
RCM
| $86K | ﹤0.01% |
10,851
-1,742
| -14% | -$15K |
|
|
ADVM
1492
DELISTED
Adverum Biotechnologies
ADVM
| $85K | ﹤0.01% |
+2,705
| New | +$110K |
|
1493
Lattice Semiconductor
LSCC
$17.6B
| $85K | ﹤0.01% |
12,337
-1,989
| -14% | -$13.4K |
|
1494
Scorpio Tankers
STNG
$3.96B
| $85K | ﹤0.01% |
4,813
+1,220
| +34% | +$22.7K |
|
|
RAD
1495
DELISTED
Rite Aid Corporation
RAD
| $85K | ﹤0.01% |
5,994
-1,006
| -14% | -$21.2K |
|
|
NPKI
1496
NPK International
NPKI
$1.21B
| $82K | ﹤0.01% |
11,943
-1,253
| -9% | -$10.2K |
|
|
DOVA
1497
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $82K | ﹤0.01% |
10,788
-2,154
| -17% | -$34.7K |
|
1498
Geron
GERN
$911M
| $81K | ﹤0.01% |
80,961
-14,585
| -15% | -$22.1K |
|
|
CMO
1499
DELISTED
Capstead Mortgage Corp.
CMO
| $81K | ﹤0.01% |
12,077
-1,519
| -11% | -$11.2K |
|
1500
Larimar Therapeutics
LRMR
$416M
| $78K | ﹤0.01% |
+1,309
| New | +$129K |
|
Similar funds
ProShare Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.
- ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
- ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
- ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
- ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
- ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
- ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
- ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.
Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.